These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37989415)
1. Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition. Chiou JT; Lee YC; Chang LS Biochem Pharmacol; 2023 Dec; 218():115934. PubMed ID: 37989415 [TBL] [Abstract][Full Text] [Related]
2. Hydroquinone destabilizes BIM mRNA through upregulation of p62 in chronic myeloid leukemia cells. Lee YC; Chiou JT; Wang LJ; Chang LS Biochem Pharmacol; 2022 May; 199():115017. PubMed ID: 35346662 [TBL] [Abstract][Full Text] [Related]
3. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Chiou JT; Huang CH; Wu TH; Wang LJ; Lee YC; Huang PW; Chang LS Toxicol Appl Pharmacol; 2022 Jan; 435():115847. PubMed ID: 34963561 [TBL] [Abstract][Full Text] [Related]
4. AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK/miR-22/HuR axis in chronic myeloid leukemia cells. Lee YC; Chiou JT; Chang LS Biochem Pharmacol; 2023 Mar; 209():115442. PubMed ID: 36720359 [TBL] [Abstract][Full Text] [Related]
5. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells. Chiou JT; Lee YC; Wang LJ; Chang LS Chem Biol Interact; 2022 Jul; 361():109978. PubMed ID: 35561756 [TBL] [Abstract][Full Text] [Related]
6. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells. Chiou JT; Lee YC; Huang CH; Shi YJ; Wang LJ; Chang LS Toxicol Appl Pharmacol; 2020 Jan; 387():114857. PubMed ID: 31837377 [TBL] [Abstract][Full Text] [Related]
7. ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells. Chiou JT; Chang LS Biochem Pharmacol; 2024 Jun; 224():116242. PubMed ID: 38679209 [TBL] [Abstract][Full Text] [Related]
8. Hydroquinone-induced miR-122 down-regulation elicits ADAM17 up-regulation, leading to increased soluble TNF-α production in human leukemia cells with expressed Bcr/Abl. Chen YJ; Chang LS Biochem Pharmacol; 2013 Sep; 86(5):620-31. PubMed ID: 23791922 [TBL] [Abstract][Full Text] [Related]
9. LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis. Han Y; Ma Z Anticancer Drugs; 2021 Apr; 32(4):427-436. PubMed ID: 33587348 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells. Chiou JT; Lee YC; Huang CH; Wang LJ; Shi YJ; Chang LS Biochem Pharmacol; 2021 Jun; 188():114544. PubMed ID: 33831396 [TBL] [Abstract][Full Text] [Related]
11. p38 MAPK/PP2Acα/TTP pathway on the connection of TNF-α and caspases activation on hydroquinone-induced apoptosis. Liu WH; Chou WM; Chang LS Carcinogenesis; 2013 Apr; 34(4):818-27. PubMed ID: 23288922 [TBL] [Abstract][Full Text] [Related]
12. Albendazole-Induced SIRT3 Upregulation Protects Human Leukemia K562 Cells from the Cytotoxicity of MCL1 Suppression. Wang LJ; Liou LR; Shi YJ; Chiou JT; Lee YC; Huang CH; Huang PW; Chang LS Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486166 [TBL] [Abstract][Full Text] [Related]
13. Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway. Lee YC; Chiou JT; Wang LJ; Chen YJ; Chang LS Toxicol Appl Pharmacol; 2023 Sep; 474():116625. PubMed ID: 37451322 [TBL] [Abstract][Full Text] [Related]
14. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia. Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353 [TBL] [Abstract][Full Text] [Related]
15. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression. Chiou JT; Chang LS Apoptosis; 2024 Apr; 29(3-4):503-520. PubMed ID: 38066391 [TBL] [Abstract][Full Text] [Related]
16. Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells. Song P; Ye L; Fan J; Li Y; Zeng X; Wang Z; Wang S; Zhang G; Yang P; Cao Z; Ju D Oncotarget; 2015 Feb; 6(6):3861-73. PubMed ID: 25738356 [TBL] [Abstract][Full Text] [Related]
17. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells. Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of Deng Y; Li X; Feng J; Zhang X Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29559564 [TBL] [Abstract][Full Text] [Related]
19. Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS/p38 MAPK/AMPK/TET2/FOXP3 axis. Chiou JT; Huang CH; Lee YC; Wang LJ; Shi YJ; Chen YJ; Chang LS Cell Biol Toxicol; 2020 Aug; 36(4):315-331. PubMed ID: 31900833 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of EGFR pathway promotes the cytotoxicity of ABT-263 in human leukemia K562 cells by blocking MCL1 upregulation. Lee YC; Wang LJ; Huang CH; Chiou JT; Shi YJ; Chang LS Biochem Pharmacol; 2020 Aug; 178():114047. PubMed ID: 32446890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]